ONYX PHARMACEUTICALS INC 4
4 · ONYX PHARMACEUTICALS INC · Filed Feb 21, 2008
Insider Transaction Report
Form 4
KENNEY EDWARD F
EVP, Chief Business Officer
Transactions
- Sale
Common Stock
2008-02-19$36.67/sh−24$880→ 28,158 total - Sale
Common Stock
2008-02-19$35.67/sh−226$8,061→ 28,182 total
Footnotes (2)
- [F1]Shares sold pursuant to a 10b5-1 plan.
- [F2]Includes an aggregate of 1,408 shares purchased in 2007 through the Issuer's ESPP.